1[1]Bou G, Oliver A, Martrinez J, et al. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain[J]. Antimicrob Agents Chemother, 2000, 44(6): 1556-1561.
2[2]Iregbu K C, Ogunsola F T, Odugbemi T O. Infections caused by Acinetobacter species and their susceptibility to 14 antibiotics in Lagos University Teaching Hospital, Lagos[J]. West Afr J med, 2002, 21(3): 226-229.
3[3]Scerpella E G, Wanger A R, Armitige L, et al. Nosocomial outbreak caused by 9 multiresistance clone of Acinetobacter baumannii; results of the case control and molecular epidemiologic investigations[J]. Infect Control Hosp Epidemiol, 1995, 16(2): 92-97.
4[5]Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, et al. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii[J]. J Antimicrob Chemother, 2003, 51(3): 565-74.
5[6]Gales A C, Tognim M C, Reis A O, et al. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital[J]. Diagn Microbiol Infect Dis, 2003, 45(1): 77-79.
6[8]Rodriguez-Bano J, Pascual A, Gavez J, et al. Acinetobacter baumannii bacteremia: clinical and prognostic features[J]. Enferm Infect Microbiol Clin, 2003, 21(5): 242-277.
7Piddock L J, Waiters RN et al. Prevalance and mechanism of resistance to" third--generation" cephalosporins in clinical relevant isolates of Enterobacter iaceae from 43 hospitals in the UK.1990 -1991[J]. J Antimicrob Chemother 1997,39(2):177-187.
8Richardson H，传染病学最新资料，1997年，13卷，4页
9Marshall JC,Cook DJ,Christou NV,et al.Multiple organ dysfunction score:a reliable descriptor of a complex clinical outcome [J].Crit Care Med,1995,23:1638-1652.
10Chastre J, Fagon JY.Ventilator-associated pneumonia[J].Am J Respir Crit Care Med,2002,165:867-903.
5Peterson LR. Squeezing the antibiotic balloon:the impact of antimincrobial classes on emerging resistance[J].Clinical Microbiology and Infection,2005,(Suppl5):4-16.
6Perez F,Hujer AM,Hujer KM. Global challenge of multidrugresistant Acinetobacter baumannii[J].Antimicrobial Agents and Chemotherapy,2007,(10):3471-3484.
